|
|
Volumn 45, Issue 4, 2013, Pages 1423-1426
|
|
Outcome of desensitization in human leukocyte antigen- and ABO-incompatible living donor kidney transplantation: A single-center experience in more than 100 patients
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CREATININE;
FLUORESCEIN ISOTHIOCYANATE;
HLA ANTIGEN;
IMMUNOGLOBULIN G;
IMMUNOGLOBULIN M;
METHYLPREDNISOLONE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PREDNISONE;
RITUXIMAB;
TACROLIMUS;
THYMOCYTE ANTIBODY;
ACUTE GRAFT REJECTION;
ADOLESCENT;
ADULT;
AGED;
ANTIBODY MEDIATED REJECTION;
B LYMPHOCYTE;
BLOOD GROUP ABO INCOMPATIBILITY;
BLOOD GROUP TYPING;
CONFERENCE PAPER;
CREATININE BLOOD LEVEL;
DESENSITIZATION;
DRUG MEGADOSE;
FEMALE;
FLOW CYTOMETRY;
FOLLOW UP;
GRAFT FAILURE;
GRAFT SURVIVAL;
HIGH RISK PATIENT;
HLA SYSTEM;
HLA TYPING;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INCIDENCE;
JOB EXPERIENCE;
KIDNEY DONOR;
KIDNEY FAILURE;
KIDNEY GRAFT;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
KIDNEY VEIN THROMBOSIS;
LEUKOCYTE;
LIVING DONOR;
LOW DRUG DOSE;
LYMPHOCYTOTOXICITY;
MAJOR CLINICAL STUDY;
MALE;
MORTALITY;
OBSERVATIONAL STUDY;
OUTCOME ASSESSMENT;
PLASMAPHERESIS;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
RECURRENT DISEASE;
SINGLE DRUG DOSE;
SURGICAL PATIENT;
SURVIVAL;
T LYMPHOCYTE;
ABO BLOOD-GROUP SYSTEM;
GRAFT REJECTION;
GRAFT SURVIVAL;
HLA ANTIGENS;
HUMANS;
KIDNEY TRANSPLANTATION;
LIVING DONORS;
SURVIVAL RATE;
TREATMENT OUTCOME;
|
|
EID: 84878588609
PISSN: 00411345
EISSN: 18732623
Source Type: Journal
DOI: 10.1016/j.transproceed.2013.01.081 Document Type: Conference Paper |
|
Times cited : (19)
|
|
References (12)
|
